Safety analysis of docetaxel (T) and doxorubicin (A) followed by sequential capecitabine (X) as adjuvant chemotherapy of patients with node-positive operable breast cancer (BC).

被引：0
|
作者：
Mayordomo, JI
Madroñal, C
Garcia-Lopez, MJ
Burillo, MA
Perez, V
Janariz, J
Murillo, L
Andres, R
Lara, R
Lambea, J
Sanz, IAJ
机构：
[1] Hosp Clin Univ, Zaragoza, Spain
[2] Inst Oncol Corachan, Barcelona, Spain
[3] Hosp Nuestra Senora Alarcos, Ciudad Real, Spain
[4] Hosp Gen San Jorge, Huesca, Spain
[5] Hosp Arritxaca, Murcia, Spain
[6] Hosp Creu Roja De Barcelona, Hosp Barcelona, Barcelona, Spain
[7] Hosp Tudela, Tudela, Navarra, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80S / 80S
页数：1
相关论文
共 50 条
  • [1] Feasibility of adjuvant chemotherapy with doxorubicin plus docetaxel followed by sequential capecitabine in patients with node positive breast cancer.
    Lara, R
    Mayordomo, JI
    Modolell, A
    Burillo, M
    Sanz, J
    Murillo, L
    Janariz, J
    Perez, V
    Andres, R
    Tres, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 72S - 72S
  • [2] Adjuvant docetaxel for node-positive breast cancer
    Noronha, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09): : 954 - 954
  • [3] Adjuvant docetaxel for node-positive breast cancer
    Martin, M
    Pienkowski, T
    Mackey, J
    Pawlicki, M
    Guastalla, JP
    Weaver, C
    Tomiak, E
    Al-Tweigeri, T
    Chap, L
    Juhos, E
    Guevin, R
    Howell, A
    Fornander, T
    Hainsworth, J
    Coleman, R
    Vinholes, J
    Modiano, M
    Pinter, T
    Tang, SC
    Colwell, B
    Prady, C
    Provencher, L
    Walde, D
    Rodriguez-Lescure, A
    Hugh, J
    Loret, C
    Rupin, M
    Blitz, S
    Jacobs, P
    Murawsky, M
    Riva, A
    Vogel, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22): : 2302 - 2313
  • [4] Doxorubicin (A) followed by docetaxel (T) versus doxorubicin plus docetaxel (AT) in the adjuvant treatment of breast cancer (BC)
    Di Leo, A
    Crown, J
    Nogaret, LM
    Duffy, K
    Bartholomeus, S
    Dolci, S
    Rowan, S
    O'Higgins, N
    Riva, A
    Piccart, MJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S41 - S41
  • [5] Weight gain after adjuvant TAC (docetaxel, doxorubicin, and cyclophosphamide) chemotherapy for node-positive breast cancer
    Suh, Y.
    Oh, S.
    Song, B.
    Jung, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [7] Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women
    Du, XLL
    Jones, DV
    Zhang, D
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (09): : 1137 - 1144
  • [8] PROGNOSTIC FACTORS IN NODE-POSITIVE OPERABLE BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
    RAKOWSKY, E
    KLEIN, B
    KAHAN, E
    DERAZNE, E
    LURIE, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1992, 21 (02) : 121 - 131
  • [9] Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: Results of a feasibility study
    Cardoso, F
    Ferreira, AF
    Crown, J
    Dolci, S
    Paesmans, M
    Riva, A
    Di Leo, A
    Piccart, MJ
    [J]. ANTICANCER RESEARCH, 2001, 21 (1B) : 789 - 795
  • [10] Prophylactic pegfilgrastim support with adjuvant docetaxel, doxorubicin and cyclophosphamide (TAC) in node-positive breast cancer patients
    Rifa, Juli
    Del Alba, A. Gonzalez
    Perello, A.
    Alarcon, J.
    Avella, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 112 - 112
12345